Use of ATR and Chk1 inhibitor compounds
US11730734B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2017 |
| Grant date | Aug 22, 2023 |
| Priority date | — |
| Expiry date | Nov 25, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating or preventing herpesvirus infection and/or herpesvirus-associated diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.